Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	guanylyltransferase activity	TENT4B TENT4A FPGT	1.79e-05	7	162	3	GO:0070568
GeneOntologyMolecularFunction	calcium ion binding	PITPNM2 NID2 PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ADGRV1 SCIN	1.29e-04	749	162	17	GO:0005509
GeneOntologyMolecularFunction	microfilament motor activity	MYH9 MYH11 MYO7A MYO7B	2.49e-04	38	162	4	GO:0000146
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CNTN4 PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.89e-10	187	163	14	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CNTN4 PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.04e-07	313	163	14	GO:0098742
GeneOntologyBiologicalProcess	sensory perception of mechanical stimulus	TRPV1 EYA4 MYO7A MYO7B TRIOBP ADGRV1 GRIN2D TECTA PKHD1L1 PIEZO2	2.04e-05	238	163	10	GO:0050954
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	3.93e-05	9	163	3	GO:0160063
GeneOntologyBiologicalProcess	polyadenylation-dependent RNA catabolic process	TENT4B TENT4A	6.21e-05	2	163	2	GO:0043633
GeneOntologyBiologicalProcess	polyadenylation-dependent ncRNA catabolic process	TENT4B TENT4A	6.21e-05	2	163	2	GO:0043634
GeneOntologyBiologicalProcess	extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration	SRGAP2 SRGAP2C	6.21e-05	2	163	2	GO:0021816
GeneOntologyCellularComponent	cluster of actin-based cell projections	MYH9 MYH11 MYO7A MYO7B TRIOBP ADGRV1 AQP7P3 PKHD1L1 AQP7 SCIN	1.04e-05	223	163	10	GO:0098862
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	3.78e-05	9	163	3	GO:0160064
GeneOntologyCellularComponent	myosin complex	MYH9 MYH11 MYO7A MYO7B DYNLL2	9.66e-05	59	163	5	GO:0016459
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	1.59e-04	14	163	3	GO:0072379
GeneOntologyCellularComponent	ciliary tip	WDR19 DYNLL2 DYNLL1 IFT122	5.31e-04	48	163	4	GO:0097542
GeneOntologyCellularComponent	photoreceptor connecting cilium	MYO7A ADGRV1 WDR19 IFT122	5.31e-04	48	163	4	GO:0032391
GeneOntologyCellularComponent	TRAMP complex	TENT4B TENT4A	5.95e-04	5	163	2	GO:0031499
MousePheno	decreased urine glycerol level	AQP7P3 AQP7	6.59e-05	2	114	2	MP:0030781
MousePheno	absent cochlear hair bundle ankle links	MYO7A ADGRV1	6.59e-05	2	114	2	MP:0004582
MousePheno	abnormal cochlear hair bundle ankle links morphology	MYO7A ADGRV1	6.59e-05	2	114	2	MP:0004581
Domain	Cadherin_tail	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.24e-18	37	159	13	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.24e-18	37	159	13	IPR031904
Domain	Cadherin_2	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	8.41e-15	65	159	13	PF08266
Domain	Cadherin_N	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	8.41e-15	65	159	13	IPR013164
Domain	CA	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FREM2	9.99e-13	115	159	14	SM00112
Domain	Cadherin	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FREM2	1.43e-12	118	159	14	IPR002126
Domain	Cadherin_CS	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	8.69e-12	109	159	13	IPR020894
Domain	CADHERIN_1	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.39e-11	113	159	13	PS00232
Domain	Cadherin	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.39e-11	113	159	13	PF00028
Domain	CADHERIN_2	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.55e-11	114	159	13	PS50268
Domain	-	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.55e-11	114	159	13	2.60.40.60
Domain	Cadherin-like	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.94e-11	116	159	13	IPR015919
Domain	srGAP2	SRGAP2 SRGAP2C SRGAP2B	6.05e-07	3	159	3	IPR030252
Domain	DUF2012	NOMO1 NOMO2 NOMO3	2.41e-06	4	159	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	2.41e-06	4	159	3	IPR019008
Domain	FCH	SRGAP2 SRGAP2C SRGAP3 SRGAP2B	3.28e-05	22	159	4	PF00611
Domain	FCH	SRGAP2 SRGAP2C SRGAP3 SRGAP2B	3.28e-05	22	159	4	SM00055
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	3.29e-05	8	159	3	IPR013784
Domain	FCH_dom	SRGAP2 SRGAP2C SRGAP3 SRGAP2B	3.95e-05	23	159	4	IPR001060
Domain	F_BAR	SRGAP2 SRGAP2C SRGAP3 SRGAP2B	5.56e-05	25	159	4	IPR031160
Domain	F_BAR	SRGAP2 SRGAP2C SRGAP3 SRGAP2B	5.56e-05	25	159	4	PS51741
Domain	Pept_M12B_GON-ADAMTSs	ADAMTS9 ADAMTS20	7.20e-05	2	159	2	IPR012314
Domain	GON	ADAMTS9 ADAMTS20	7.20e-05	2	159	2	PS51046
Domain	GON	ADAMTS9 ADAMTS20	7.20e-05	2	159	2	PF08685
Domain	Dynein_light_1/2_CS	DYNLL2 DYNLL1	7.20e-05	2	159	2	IPR019763
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	1.63e-04	13	159	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	1.63e-04	13	159	3	2.60.40.1120
Domain	TILa_dom	TECTA FCGBP	2.15e-04	3	159	2	IPR025615
Domain	DUF3496	ANKRD26 ANKRD18A	2.15e-04	3	159	2	IPR021885
Domain	Dynein_light	DYNLL2 DYNLL1	2.15e-04	3	159	2	PF01221
Domain	TILa	TECTA FCGBP	2.15e-04	3	159	2	PF12714
Domain	DUF3496	ANKRD26 ANKRD18A	2.15e-04	3	159	2	PF12001
Domain	DYNEIN_LIGHT_1	DYNLL2 DYNLL1	2.15e-04	3	159	2	PS01239
Domain	Dynein_light	DYNLL2 DYNLL1	2.15e-04	3	159	2	SM01375
Domain	Dynein_light_chain_typ-1/2	DYNLL2 DYNLL1	2.15e-04	3	159	2	IPR001372
Domain	-	DYNLL2 DYNLL1	2.15e-04	3	159	2	3.30.740.10
Domain	Myosin_head_motor_dom	MYH9 MYH11 MYO7A MYO7B	2.98e-04	38	159	4	IPR001609
Domain	MYOSIN_MOTOR	MYH9 MYH11 MYO7A MYO7B	2.98e-04	38	159	4	PS51456
Domain	Myosin_head	MYH9 MYH11 MYO7A MYO7B	2.98e-04	38	159	4	PF00063
Domain	MYSc	MYH9 MYH11 MYO7A MYO7B	2.98e-04	38	159	4	SM00242
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	3.77e-04	17	159	3	IPR008969
Domain	IQ	MYH9 MYH11 MYO7A MYO7B XKR7	6.39e-04	81	159	5	SM00015
Domain	NIDO_dom	NID2 TECTA	7.08e-04	5	159	2	IPR003886
Domain	NIDO	NID2 TECTA	7.08e-04	5	159	2	SM00539
Domain	NIDO	NID2 TECTA	7.08e-04	5	159	2	PF06119
Domain	NIDO	NID2 TECTA	7.08e-04	5	159	2	PS51220
Domain	IQ_motif_EF-hand-BS	MYH9 MYH11 MYO7A MYO7B XKR7	1.03e-03	90	159	5	IPR000048
Domain	PKD	PKD1L1 SORCS3	1.47e-03	7	159	2	PF00801
Domain	PAP_assoc	TENT4B TENT4A	1.47e-03	7	159	2	PF03828
Domain	PAP_assoc	TENT4B TENT4A	1.47e-03	7	159	2	IPR002058
Domain	Calx_beta	ADGRV1 FREM2	1.95e-03	8	159	2	SM00237
Domain	Calx_beta	ADGRV1 FREM2	2.49e-03	9	159	2	IPR003644
Domain	MYTH4	MYO7A MYO7B	2.49e-03	9	159	2	PS51016
Domain	MyTH4	MYO7A MYO7B	2.49e-03	9	159	2	SM00139
Domain	MyTH4_dom	MYO7A MYO7B	2.49e-03	9	159	2	IPR000857
Domain	MyTH4	MYO7A MYO7B	2.49e-03	9	159	2	PF00784
Domain	Calx-beta	ADGRV1 FREM2	2.49e-03	9	159	2	PF03160
Domain	C1Q	CBLN2 C1QTNF1 C1QTNF2	2.51e-03	32	159	3	SM00110
Domain	C1q	CBLN2 C1QTNF1 C1QTNF2	2.51e-03	32	159	3	PF00386
Domain	C1q_dom	CBLN2 C1QTNF1 C1QTNF2	2.99e-03	34	159	3	IPR001073
Domain	C1Q	CBLN2 C1QTNF1 C1QTNF2	2.99e-03	34	159	3	PS50871
Domain	IQ	MYH9 MYH11 MYO7A MYO7B	3.16e-03	71	159	4	PF00612
Domain	GPS	PKD1L1 ADGRV1 ADGRG6	3.52e-03	36	159	3	PS50221
Domain	NTP_transf_2	TENT4B TENT4A	3.77e-03	11	159	2	PF01909
Domain	Polymerase_NTP_transf_dom	TENT4B TENT4A	3.77e-03	11	159	2	IPR002934
Domain	PKD	PKD1L1 SORCS3	3.77e-03	11	159	2	PS50093
Domain	PKD_dom	PKD1L1 SORCS3	3.77e-03	11	159	2	IPR000601
Domain	-	PKD1L1 SORCS3	3.77e-03	11	159	2	2.60.40.670
Domain	GPS	PKD1L1 ADGRV1 ADGRG6	3.80e-03	37	159	3	IPR000203
Domain	C8	TECTA FCGBP	4.49e-03	12	159	2	PF08742
Domain	TIL	TECTA FCGBP	4.49e-03	12	159	2	PF01826
Domain	Unchr_dom_Cys-rich	TECTA FCGBP	5.28e-03	13	159	2	IPR014853
Domain	C8	TECTA FCGBP	5.28e-03	13	159	2	SM00832
Domain	Collagen	COL12A1 C1QTNF1 C1QTNF2 SCARA3	6.00e-03	85	159	4	IPR008160
Domain	Collagen	COL12A1 C1QTNF1 C1QTNF2 SCARA3	6.00e-03	85	159	4	PF01391
Domain	TIL_dom	TECTA FCGBP	6.13e-03	14	159	2	IPR002919
Domain	CNH	GARNL3 NRK	6.13e-03	14	159	2	SM00036
Domain	FERM_M	MYO7A MYO7B FRMPD1	7.03e-03	46	159	3	PF00373
Domain	Myosin_N	MYH9 MYH11	7.03e-03	15	159	2	PF02736
Domain	CNH	GARNL3 NRK	7.03e-03	15	159	2	PF00780
Domain	Myosin_N	MYH9 MYH11	7.03e-03	15	159	2	IPR004009
Domain	CNH	GARNL3 NRK	7.03e-03	15	159	2	PS50219
Domain	CNH_dom	GARNL3 NRK	7.03e-03	15	159	2	IPR001180
Domain	VWF_type-D	TECTA FCGBP	7.99e-03	16	159	2	IPR001846
Domain	VWFD	TECTA FCGBP	7.99e-03	16	159	2	PS51233
Domain	VWD	TECTA FCGBP	7.99e-03	16	159	2	SM00216
Domain	VWD	TECTA FCGBP	7.99e-03	16	159	2	PF00094
Domain	IQ	MYH9 MYH11 MYO7A MYO7B	8.22e-03	93	159	4	PS50096
Domain	CUB	CSMD3 ADGRG6 ATRNL1	8.38e-03	49	159	3	PF00431
Domain	-	MYO7A MYO7B FRMPD1	8.38e-03	49	159	3	1.20.80.10
Domain	FERM_central	MYO7A MYO7B FRMPD1	8.38e-03	49	159	3	IPR019748
Domain	FERM_domain	MYO7A MYO7B FRMPD1	8.38e-03	49	159	3	IPR000299
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	3.96e-29	15	165	13	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	8.91e-28	17	165	13	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	3.20e-27	18	165	13	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	3.20e-27	18	165	13	10662547
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	9.08e-25	24	165	13	24698270
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.34e-23	28	165	13	15347688
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4	4.80e-23	11	165	10	9655502
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	7.79e-19	57	165	13	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.00e-18	58	165	13	30377227
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	9.54e-18	68	165	13	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.12e-17	72	165	13	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	3.11e-17	74	165	13	10817752
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	3.74e-17	75	165	13	15372022
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.39e-17	77	165	13	10835267
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	EYA4 PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 CP PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NSG2 ADAMTS9	6.40e-17	193	165	17	22589738
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	9.13e-17	80	165	13	10716726
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4	1.05e-16	12	165	8	10612399
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.93e-14	119	165	13	28625976
Pubmed	Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease.	PCDHA9 PCDHA12 PCDHA10 PCDHA7	2.43e-09	5	165	4	34888534
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	PCDHA9 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 PCDHA2 PCDHA1 GRIN2D	6.52e-08	329	165	12	17474147
Pubmed	Inhibition of SRGAP2 function by its human-specific paralogs induces neoteny during spine maturation.	SRGAP2 SRGAP2C SRGAP2B	1.05e-07	3	165	3	22559944
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	1.05e-07	3	165	3	36011023
Pubmed	Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease.	PCDHA9 PCDHA12 PCDHA10	1.05e-07	3	165	3	29477871
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	1.05e-07	3	165	3	25576386
Pubmed	Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication.	SRGAP2 SRGAP2C SRGAP2B	4.18e-07	4	165	3	22559943
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	4.18e-07	4	165	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	4.18e-07	4	165	3	9267806
Pubmed	DAJIN enables multiplex genotyping to simultaneously validate intended and unintended target genome editing outcomes.	CABLES2 TYR EXOC7	3.62e-06	7	165	3	35041655
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	5.77e-06	8	165	3	15257293
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MYH9 TENT4B MYO7A SH2D3C MCM3 APOB TECTA CSMD3 DOCK5 ADAMTS20 PLA2G6 SCIN	6.86e-06	513	165	12	25798074
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	8.63e-06	9	165	3	36261522
Pubmed	Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model.	PCDHA11 PCDHA5 PCDHA4	8.63e-06	9	165	3	12154121
Pubmed	Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes.	PCDHA12 PCDHA10 PCDHA8 PCDHA6 PCDHA1	9.21e-06	59	165	5	23754746
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	NID2 FN1 APOB ADAMTS9 ADAMTS20	1.38e-05	64	165	5	22261194
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	SSR4 NOMO1 NOMO2 NOMO3	1.39e-05	31	165	4	19136429
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	1.68e-05	11	165	3	32820719
Pubmed	Genetic Hearing Loss Overview	MYH9 EYA4 MYO7A TRIOBP TECTA	2.13e-05	70	165	5	20301607
Pubmed	Influence of gene duplication and X-inactivation on mouse mitochondrial malic enzyme activity and electrophoretic patterns.	MYO7A TYR	2.24e-05	2	165	2	863237
Pubmed	Comparative proteomic analysis of cellular response of human airway epithelial cells (A549) to benzo(a)pyrene.	CAT GSR	2.24e-05	2	165	2	21417634
Pubmed	Over-expression of AQP7 contributes to improve insulin resistance in adipocytes.	AQP7P3 AQP7	2.24e-05	2	165	2	22877989
Pubmed	Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.	TRPV1 F2RL1	2.24e-05	2	165	2	19812353
Pubmed	Molecular analysis of radiation-induced albino (c)-locus mutations that cause death at preimplantation stages of development.	MYO7A TYR	2.24e-05	2	165	2	8307326
Pubmed	SRGAP2 and Its Human-Specific Paralog Co-Regulate the Development of Excitatory and Inhibitory Synapses.	SRGAP2 SRGAP2C	2.24e-05	2	165	2	27373832
Pubmed	Affinity, avidity, and kinetics of target sequence binding to LC8 dynein light chain isoforms.	DYNLL2 DYNLL1	2.24e-05	2	165	2	20889982
Pubmed	Aquaporin 7 is upregulated through the PI3K-Akt pathway and modulates decidualisation of endometrial stromal cells.	AQP7P3 AQP7	2.24e-05	2	165	2	37879294
Pubmed	Prolonged Starvation Causes Up-Regulation of AQP1 in Adipose Tissue Capillaries of AQP7 Knock-Out Mice.	AQP7P3 AQP7	2.24e-05	2	165	2	27455244
Pubmed	Involvement of aquaporin-7 in the cutaneous primary immune response through modulation of antigen uptake and migration in dendritic cells.	AQP7P3 AQP7	2.24e-05	2	165	2	21968069
Pubmed	PCDHA9 as a candidate gene for amyotrophic lateral sclerosis.	PCDHA12 PCDHA10	2.24e-05	2	165	2	38467605
Pubmed	Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases.	MYH9 ANKRD26	2.24e-05	2	165	2	29545013
Pubmed	Aquaporin-7 Facilitates Proliferation and Adipogenic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells by Regulating Hydrogen Peroxide Transport.	AQP7P3 AQP7	2.24e-05	2	165	2	37432580
Pubmed	PAR-2 activation enhances weak acid-induced ATP release through TRPV1 and ASIC sensitization in human esophageal epithelial cells.	TRPV1 F2RL1	2.24e-05	2	165	2	26294672
Pubmed	Aquaporin 7 is a beta-cell protein and regulator of intraislet glycerol content and glycerol kinase activity, beta-cell mass, and insulin production and secretion.	AQP7P3 AQP7	2.24e-05	2	165	2	17576812
Pubmed	The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin.	TENT4B TENT4A	2.24e-05	2	165	2	10066793
Pubmed	The inverse F-BAR domain protein srGAP2 acts through srGAP3 to modulate neuronal differentiation and neurite outgrowth of mouse neuroblastoma cells.	SRGAP2 SRGAP3	2.24e-05	2	165	2	23505444
Pubmed	Retinal pigment epithelium defects in humans and mice with mutations in MYO7A: imaging melanosome-specific autofluorescence.	MYO7A TYR	2.24e-05	2	165	2	19324852
Pubmed	Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.	TENT4B TENT4A	2.24e-05	2	165	2	32559291
Pubmed	[The study of the antioxidant enzymes in erythrocytes in lung diseases].	CAT GSR	2.24e-05	2	165	2	12838770
Pubmed	Aquaporin 7 expression in postimplantation mouse uteri: a potential role for glycerol transport in uterine decidualization.	AQP7P3 AQP7	2.24e-05	2	165	2	21130427
Pubmed	The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator.	AQP7P3 AQP7	2.24e-05	2	165	2	19297367
Pubmed	Dynamic subcellular localization of aquaporin-7 in white adipocytes.	AQP7P3 AQP7	2.24e-05	2	165	2	25643985
Pubmed	Molecular characterization of human Aquaporin-7 gene and its chromosomal mapping.	AQP7P3 AQP7	2.24e-05	2	165	2	9714739
Pubmed	Cryoprotectants up-regulate expression of mouse oocyte AQP7, which facilitates water diffusion during cryopreservation.	AQP7P3 AQP7	2.24e-05	2	165	2	23290745
Pubmed	Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation.	TENT4B TENT4A	2.24e-05	2	165	2	30026317
Pubmed	Oral cancer induced TRPV1 sensitization is mediated by PAR2 signaling in primary afferent neurons innervating the cancer microenvironment.	TRPV1 F2RL1	2.24e-05	2	165	2	35260737
Pubmed	Aquaporin-7 Regulates the Response to Cellular Stress in Breast Cancer.	AQP7P3 AQP7	2.24e-05	2	165	2	32631905
Pubmed	The human-specific paralogs SRGAP2B and SRGAP2C differentially modulate SRGAP2A-dependent synaptic development.	SRGAP2C SRGAP2B	2.24e-05	2	165	2	31822692
Pubmed	Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel.	AQP7P3 AQP7	2.24e-05	2	165	2	11457862
Pubmed	Cardioprotective effect of St. Thomas' Hospital No. 2 solution against age-related changes in aquaporin-7-deficient mice.	AQP7P3 AQP7	2.24e-05	2	165	2	37691043
Pubmed	Aquaporin7 expression during perinatal development of mouse brain.	AQP7P3 AQP7	2.24e-05	2	165	2	17052846
Pubmed	Acute phase immune response to exercise coexists with decreased neutrophil antioxidant enzyme defences.	CAT GSR	2.24e-05	2	165	2	12516882
Pubmed	Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.	ADAMTS9 ADAMTS20	2.24e-05	2	165	2	12514189
Pubmed	Intron-less processed Pcdhalpha genes in the central nervous system.	PCDHA8 PCDHA6	2.24e-05	2	165	2	14697259
Pubmed	Morphologic and functional analysis of sperm and testes in Aquaporin 7 knockout mice.	AQP7P3 AQP7	2.24e-05	2	165	2	17123523
Pubmed	Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9.	AQP7P3 AQP7	2.24e-05	2	165	2	11972053
Pubmed	Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue.	AQP7P3 AQP7	2.24e-05	2	165	2	15591341
Pubmed	The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice.	TRPV1 F2RL1	2.24e-05	2	165	2	20932849
Pubmed	Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation.	AQP7P3 AQP7	2.24e-05	2	165	2	15746100
Pubmed	Aquaporin7 plays a crucial role in tolerance to hyperosmotic stress and in the survival of oocytes during cryopreservation.	AQP7P3 AQP7	2.24e-05	2	165	2	26634435
Pubmed	AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism.	AQP7P3 AQP7	2.24e-05	2	165	2	17077387
Pubmed	A new role for aquaporin 7 in insulin secretion.	AQP7P3 AQP7	2.24e-05	2	165	2	22415076
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	STXBP4 ANKRD26 C15orf39 MCM3 SORBS1 GSR NOMO2 DYNLL2 KIF14 DYNLL1 SCIN CDC23	2.64e-05	588	165	12	38580884
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	CNTN4 FN1 CP APOB ADGRG6 FREM2 FCGBP PTPRJ	3.37e-05	257	165	8	16335952
Pubmed	Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth.	MYO7A TRIOBP ADGRV1	3.67e-05	14	165	3	26754646
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYH9 MYO7A MYO7B	3.67e-05	14	165	3	8022818
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	MYH9 ANKRD26 ADGRV1 FCGBP NSG2	5.16e-05	84	165	5	15203218
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	COL12A1 FN1 CP APOB	5.72e-05	44	165	4	31273033
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYH9 MYH11 MYO7B SCIN	6.25e-05	45	165	4	22114352
Pubmed	Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9.	AQP7P3 AQP7	6.69e-05	3	165	2	12351427
Pubmed	Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes.	AQP7P3 AQP7	6.69e-05	3	165	2	20573496
Pubmed	Mammalian Auditory Hair Cell Bundle Stiffness Affects Frequency Tuning by Increasing Coupling along the Length of the Cochlea.	TRIOBP TECTA	6.69e-05	3	165	2	29874579
Pubmed	Defective water and glycerol transport in the proximal tubules of AQP7 knockout mice.	AQP7P3 AQP7	6.69e-05	3	165	2	15998844
Pubmed	Deletion mapping of four loci defined by N-ethyl-N-nitrosourea-induced postimplantation-lethal mutations within the pid-Hbb region of mouse chromosome 7.	MYO7A TYR	6.69e-05	3	165	2	8307327
Pubmed	Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase.	AQP7P3 AQP7	6.69e-05	3	165	2	16009937
Pubmed	Two novel CNRs from the CNR gene cluster have molecular features distinct from those of CNR1 to 8.	PCDHA2 PCDHA1	6.69e-05	3	165	2	11401448
Pubmed	The Genetic Landscape of Hypoplastic Left Heart Syndrome.	PCDHA12 PCDHA10	6.69e-05	3	165	2	29569026
Pubmed	Close linkage of the olfactory marker protein gene to the mouse deafness mutation shaker-1.	MYO7A TYR	6.69e-05	3	165	2	1349573
Pubmed	Molecular Sensors of Temperature, Pressure, and Pain with Special Focus on TRPV1, TRPM8, and PIEZO2 Ion Channels.	TRPV1 PIEZO2	6.69e-05	3	165	2	34825354
Pubmed	Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins.	PCDHA9 PCDHA7	6.69e-05	3	165	2	27161523
Pubmed	Air1 zinc knuckles 4 and 5 and a conserved IWRXY motif are critical for the function and integrity of the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) RNA quality control complex.	TENT4B TENT4A	6.69e-05	3	165	2	21878619
Pubmed	Expression of aquaporin-7 and aquaporin-9 in tanycyte cells and choroid plexus during mouse estrus cycle.	AQP7P3 AQP7	6.69e-05	3	165	2	27746040
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2	2.13e-20	22	158	12	int:PCDHA10
Interaction	PCDHA7 interactions	PCDHA9 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA4 PCDHA2	5.22e-12	14	158	7	int:PCDHA7
Interaction	PCDHA8 interactions	PCDHA13 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.42e-11	55	158	10	int:PCDHA8
Interaction	PCDHA11 interactions	PCDHA9 PCDHA12 PCDHA11 PCDHA10 PCDHA4 PCDHA3 PCDHA1	7.42e-11	19	158	7	int:PCDHA11
Interaction	PCDHA1 interactions	PCDHA11 PCDHA8 PCDHA4 PCDHA3 PCDHA1	3.42e-09	9	158	5	int:PCDHA1
Interaction	PCDHA3 interactions	PCDHA9 PCDHA11 PCDHA10 PCDHA8 PCDHA6 PCDHA3 PCDHA1	7.17e-09	34	158	7	int:PCDHA3
Interaction	PCDHA4 interactions	PCDHA9 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA4 PCDHA1	2.16e-08	60	158	8	int:PCDHA4
Interaction	PCDHA9 interactions	PCDHA9 PCDHA11 PCDHA10 PCDHA7 PCDHA4 PCDHA3	1.62e-07	32	158	6	int:PCDHA9
Interaction	FLT3 interactions	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 APOB PCDHA1	2.22e-07	318	158	14	int:FLT3
Interaction	PCDHGA10 interactions	PCDHA9 PCDHA12 PCDHA11 PCDHA8 PCDHA4	2.96e-07	19	158	5	int:PCDHGA10
Interaction	PCDHA6 interactions	PCDHA10 PCDHA8 PCDHA6 PCDHA3	4.44e-07	9	158	4	int:PCDHA6
Interaction	LONP2 interactions	PCDHA9 PCDHA12 PCDHA11 PCDHA8 CAT PCDHA4 PCDHA3	5.46e-07	62	158	7	int:LONP2
Interaction	PCDHA12 interactions	PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA4	1.53e-06	46	158	6	int:PCDHA12
Interaction	PCDHA2 interactions	PCDHA10 PCDHA8 PCDHA7 PCDHA2	3.42e-06	14	158	4	int:PCDHA2
Interaction	PCDHA13 interactions	PCDHA13 PCDHA10 PCDHA8	1.62e-05	7	158	3	int:PCDHA13
Interaction	MLYCD interactions	PCDHA9 PCDHA12 PCDHA10 PCDHA3	8.50e-05	30	158	4	int:MLYCD
Interaction	FBXO2 interactions	NID2 COL12A1 FN1 ADGRV1 ADGRG6 NOMO1 PTPRJ OLFM2 SLAMF7 SCARA3 NOMO3 IGSF3	9.98e-05	411	158	12	int:FBXO2
Cytoband	5q31	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CDC23	8.90e-18	115	165	14	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CDC23	5.21e-12	298	165	14	chr5q31
Cytoband	5q13	ENC1 ADGRV1 F2RL1	6.68e-05	22	165	3	5q13
Cytoband	22q13.1	MYH9 TRIOBP KCNJ4 PLA2G6	2.60e-04	85	165	4	22q13.1
GeneFamily	Clustered protocadherins	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.75e-16	64	117	13	20
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	SRGAP2 SRGAP2C SRGAP3 SRGAP2B	1.34e-05	23	117	4	1288
GeneFamily	A-kinase anchoring proteins\|Myosins, class VII\|Deafness associated genes\|FERM domain containing	MYO7A MYO7B	4.15e-05	2	117	2	1102
GeneFamily	Actins\|Deafness associated genes	MYH9 MYO7A TRIOBP S1PR2 TECTA	8.38e-04	113	117	5	1152
GeneFamily	Non-canonical poly(A) polymerases	TENT4B TENT4A	8.54e-04	7	117	2	1318
GeneFamily	Dyneins, cytoplasmic	DYNLL2 DYNLL1	3.09e-03	13	117	2	538
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	9.76e-09	261	162	13	MM1277
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	3.22e-08	238	162	12	M2020
Coexpression	RUAN_RESPONSE_TO_TNF_DN	ACADM SORBS1 AQP7P3 AQP7 PLA2G6 ALDH1A1	1.12e-05	81	162	6	MM1175
Coexpression	GOLUB_ALL_VS_AML_UP	ACADM MCM3 DYNLL1 TOP2B	1.36e-05	24	162	4	M4275
Coexpression	GSE3982_NKCELL_VS_TH1_UP	FRMPD1 CAT APOB ADGRV1 YIPF1 UPK3A EXOC7 MUTYH	3.02e-05	195	162	8	M5593
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	PCDHA13 PCDHA11 PCDHA10 PCDHA4 PCDHA2 SORCS3	4.43e-05	103	162	6	M1967
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA2 SORCS3	5.20e-05	106	162	6	MM1265
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CNTN4 MYO7A RAPGEF5 ENC1 PCDHA7 SORBS1 PEX5L CSMD3 FMNL2 PIEZO2 ZNF28 NSG2 SRGAP3 CBLN2 PLXNA4 SORCS3 ANKRD18A SCIN IGSF3	5.65e-05	1106	162	19	M39071
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_100	CNTN4 COL12A1 ACTR6 NRK PLXNA4 ALDH1A1	2.03e-05	75	158	6	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500	CCNJL CNTN4 MYH11 COL12A1 FMNL2 FREM2 SRGAP3 ACTR6 ATRNL1 NRK PLXNA4 ALDH1A1	3.26e-05	385	158	12	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100	CNTN4 COL12A1 ACTR6 NRK PLXNA4 ALDH1A1	4.16e-05	85	158	6	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	FN1 PCDHA13 PCDHA12 PCDHA10 PCDHA6 PCDHA5 PCDHA4 PCDHA1 F2RL1 C1QTNF1	5.02e-05	281	158	10	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	FN1 PCDHA13 PCDHA12 PCDHA10 PCDHA6 PCDHA5 PCDHA4 PCDHA1 F2RL1 C1QTNF1	5.02e-05	281	158	10	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200	CNTN4 COL12A1 SRGAP3 ACTR6 ATRNL1 PLXNA4 ALDH1A1	7.57e-05	137	158	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200
CoexpressionAtlas	DE blastocyst_vs_DE cord blood-Confounder_removed-fold2.0_adjp0.05	ENC1 PCDHA10 PCDHA6 PCDHA4 PCDHA1 ALDH1A1	7.77e-05	95	158	6	PCBC_ratio_DE blastocyst_vs_DE cord blood_cfr-2X-p05
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500	EYA4 COL12A1 GARNL3 FN1 ABCC9 CSMD3 PIEZO2 EML5 NSG2 NRK PLXNA4	1.09e-04	371	158	11	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200	CNTN4 COL12A1 ACTR6 ATRNL1 NRK PLXNA4 ALDH1A1	1.45e-04	152	158	7	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000	CNTN4 GARNL3 FN1 PCDHA12 PCDHA11 PCDHA4 APOB ADGRV1 NSG2 KCNJ4 ATRNL1 NRK CBLN2 ADAMTS20 SORCS3 UPK3A OLFM2 CFAP61 SERTM1	1.54e-04	994	158	19	PCBC_EB_1000
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C COL12A1 MYO7B APOB ADGRV1 CSMD3 PKHD1L1 FREM2 PIEZO2 NRK ADAMTS20	8.85e-11	184	163	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C COL12A1 MYO7B APOB ADGRV1 CSMD3 PKHD1L1 FREM2 PIEZO2 NRK ADAMTS20	8.85e-11	184	163	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C COL12A1 MYO7B APOB ADGRV1 CSMD3 PKHD1L1 FREM2 PIEZO2 NRK ADAMTS20	8.85e-11	184	163	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTN4 MYH9 MYH11 EYA4 COL12A1 ENC1 ABCC9 ATRNL1 PLXNA4 OLFM2	2.74e-09	194	163	10	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EYA4 COL12A1 FN1 F2RL1 FMNL2 ADAMTS9 ATRNL1 PLXNA4 SCARA3	2.49e-08	182	163	9	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH9 MYH11 EYA4 SORBS1 FMNL2 ADAMTS9 ATRNL1 PLXNA4 SCARA3	2.87e-08	185	163	9	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 MYH11 COL12A1 FN1 ENC1 ABCC9 SORBS1 PIEZO2 ATRNL1	3.78e-08	191	163	9	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 MYH11 COL12A1 FN1 ENC1 ABCC9 SORBS1 PIEZO2 ATRNL1	3.78e-08	191	163	9	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 FN1 ADAMTS9 NRK C1QTNF1 C1QTNF2 SCIN SCARA3 IGSF3	4.51e-08	195	163	9	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTN4 MYH11 COL12A1 MYO7B ADGRV1 TECTA PKHD1L1 TYR	1.40e-07	160	163	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTN4 MYH11 COL12A1 MYO7B ADGRV1 TECTA PKHD1L1 TYR	1.40e-07	160	163	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTN4 MYH11 PCDHA9 STXBP4 ABCC9 PCDHA4 ADGRG6 ADAMTS9	3.30e-07	179	163	8	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 EYA4 COL12A1 FN1 ENC1 ADGRG6 ATRNL1 PLXNA4	3.59e-07	181	163	8	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTN4 MYH11 COL12A1 FN1 SORBS1 PLXNA4 C1QTNF2 SEL1L2	4.06e-07	184	163	8	54e5b63f55b8d6eccad53d389ea9c78f991e1414
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTN4 MYH11 COL12A1 FN1 SORBS1 PLXNA4 C1QTNF2 SEL1L2	4.06e-07	184	163	8	7b5678718719020b52e7c2a7bd9797987defd7ff
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH11 PCDHA9 STXBP4 PCDHA10 ABCC9 PCDHA5 PCDHA3 ADGRG6	4.41e-07	186	163	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NID2 EYA4 COL12A1 ADAMTS9 CBLN2 SCIN BBOX1 SCARA3	4.59e-07	187	163	8	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NID2 EYA4 COL12A1 ADAMTS9 CBLN2 SCIN BBOX1 SCARA3	4.59e-07	187	163	8	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENC1 CP CAT CPB1 ADGRG6 ADAMTS9 ALDH1A1 SCARA3	4.59e-07	187	163	8	9aa411ae9b5a923378a5daebb8bb2fc2613f2510
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NID2 EYA4 COL12A1 ADAMTS9 CBLN2 SCIN BBOX1 SCARA3	4.59e-07	187	163	8	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 EYA4 COL12A1 FN1 ADGRG6 ATRNL1 PLXNA4 SCARA3	4.59e-07	187	163	8	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	MYH11 EYA4 COL12A1 FN1 ADGRG6 ATRNL1 PLXNA4 SCARA3	4.98e-07	189	163	8	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	droplet-Kidney-nan-3m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL NID2 CP F2RL1 SULT2B1 SORCS3 UPK3A SCIN	5.61e-07	192	163	8	8b625c22dda23c99654c82c529a1233e99e71b54
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTN4 MYH9 MYH11 EYA4 COL12A1 ENC1 ATRNL1 PLXNA4	5.84e-07	193	163	8	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MYH11 EYA4 COL12A1 ENC1 ADGRG6 ATRNL1 PLXNA4 SCARA3	5.84e-07	193	163	8	2f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	NID2 CPB1 PEX5L PKHD1L1 ADAMTS9 ATRNL1 NRK CBLN2	7.35e-07	199	163	8	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CNTN4 MYH9 MYH11 ABCC9 ADGRG6 CBLN2 C1QTNF1 OLFM2	7.64e-07	200	163	8	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE1C CP TECTA CSMD3 CBLN2 SORCS3 IGSF3	1.04e-06	144	163	7	7de962346ba9653d90dd13bb7d977fe44d200bba
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 EYA4 FN1 ADGRG6 ATRNL1 PLXNA4 SCARA3	2.48e-06	164	163	7	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PEX5L PKHD1L1 ADGRG6 ATRNL1 CBLN2 SCARA3 SERTM1	2.48e-06	164	163	7	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	Control-Epithelial_airway-Club_cells-Airway\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EYA4 CP ADGRV1 FREM2 ALDH1A1 SLAMF7 SCIN	2.92e-06	168	163	7	ce87981f4da2779de952c2e5d2bbcdabb265e705
ToppCell	Control-Epithelial_airway-Club_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EYA4 CP ADGRV1 FREM2 ALDH1A1 SLAMF7 SCIN	2.92e-06	168	163	7	e85bc5398eb36b2b0773a8a7082e3ba740452165
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 PKHD1L1 SLC18A1 PLXNA4 SORCS3 UPK3A	3.03e-06	169	163	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRV1 FREM2 PLXNA4 RBM15B TOMM40 ALDH1A1 SERTM1	3.28e-06	171	163	7	b51bbeacb172e8b5de519ada85543d7ae9914b3c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CNTN4 CP SORBS1 CSMD3 CBLN2 SORCS3 IGSF3	3.96e-06	176	163	7	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 EYA4 SORBS1 ADGRG6 ATRNL1 PLXNA4 SCARA3	4.11e-06	177	163	7	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDHA12 CPB1 PKHD1L1 ADGRG6 KCNJ4 ADAMTS20 SERTM1	4.43e-06	179	163	7	056df2aaff750e0e283e7da78fcc3c90c366aac0
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDHA12 CPB1 PKHD1L1 ADGRG6 KCNJ4 ADAMTS20 SERTM1	4.43e-06	179	163	7	f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	CNTN4 NID2 MYH11 COL12A1 PCDHA7 ADGRG6 NSG2	4.77e-06	181	163	7	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH11 COL12A1 FN1 PCDHA10 APOB NRK SCARA3	4.77e-06	181	163	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	CNTN4 PDE1C FN1 RAPGEF5 ABCC9 ADAMTS9 OLFM2	4.94e-06	182	163	7	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FMNL2 ADGRG6 DOCK5 ATRNL1 PLXNA4 C1QTNF2 SCARA3	5.12e-06	183	163	7	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CP TECTA F2RL1 ADGRG6 SULT2B1 SORCS3 SCIN	5.12e-06	183	163	7	877559962b2b073fc2a9f1b64a76e17895e40a97
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 CP F2RL1 ADGRG6 SULT2B1 SORCS3 SCIN	5.50e-06	185	163	7	502361b041a036de024eb5fe378ca09fac9b67ee
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 FMNL2 ADGRG6 ATRNL1 PLXNA4 C1QTNF2 SCARA3	5.50e-06	185	163	7	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	CPB1 PKHD1L1 ADGRG6 ADAMTS9 ATRNL1 C1QTNF1 SERTM1	5.50e-06	185	163	7	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL NID2 CP F2RL1 SULT2B1 SORCS3 SCIN	6.11e-06	188	163	7	c300accbac71a3bc075fe985543d8a8ead82531b
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 EYA4 SORBS1 ADGRG6 ATRNL1 PLXNA4 SCARA3	6.11e-06	188	163	7	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 CNTN4 MYH11 EYA4 COL12A1 ATRNL1 PLXNA4	6.11e-06	188	163	7	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	CNTN4 PDE1C MYH9 SH2D3C ADGRG6 ADAMTS9 SCIN	6.33e-06	189	163	7	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CP F2RL1 ADGRG6 FCGBP SORCS3 UPK3A SCIN	6.33e-06	189	163	7	319e42f6e2322208de78bc666fb2c074707eb4da
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYH11 EYA4 ENC1 ADGRG6 ATRNL1 PLXNA4 SCARA3	6.55e-06	190	163	7	d24af6af3271e34afab744352afd28be8a7cc5c3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1C CAT ADGRV1 FCGBP SULT2B1 SRGAP3 PLXNA4	6.55e-06	190	163	7	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	MYH11 EYA4 SORBS1 ADGRG6 ATRNL1 PLXNA4 SCARA3	6.55e-06	190	163	7	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTN4 NID2 MYH11 STXBP4 PCDHA11 ADGRG6 ADAMTS9	6.55e-06	190	163	7	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FN1 MYO7A PKHD1L1 DOCK5 PIEZO2 ALDH1A1 HOMER3	6.55e-06	190	163	7	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1C CAT ADGRV1 FCGBP SULT2B1 SRGAP3 PLXNA4	6.55e-06	190	163	7	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 CNTN4 MYH11 COL12A1 ATRNL1 PLXNA4 C1QTNF1	6.55e-06	190	163	7	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 COL12A1 FN1 ABCC9 SORBS1 PIEZO2 ATRNL1	6.55e-06	190	163	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTN4 NID2 MYH11 STXBP4 PCDHA11 ADGRG6 ADAMTS9	6.55e-06	190	163	7	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 FRMPD1 PKHD1L1 KIF24 ADGRG6 NRK IGSF3	6.78e-06	191	163	7	4bfdf44d4402a42530d30c89d94946acdda4321b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 ABCC9 ADGRG6 ATRNL1 C1QTNF1 C1QTNF2 SCARA3	6.78e-06	191	163	7	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	(5)_Epi_basal\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CNTN4 ENC1 CP ADAMTS9 SRGAP3 ALDH1A1 SCARA3	6.78e-06	191	163	7	6bda3d5a8a391d41bb4d65872492e6c094bcc4d4
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTN4 EYA4 COL12A1 ABCC9 DOCK5 PIEZO2 ATRNL1	7.02e-06	192	163	7	4022f208eb5db760abd0aac782a25e8ab63efc64
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACADM ENC1 CP CAT ADGRG6 ALDH1A1 SCARA3	7.02e-06	192	163	7	f3133bbbf938a39062a9b1d1181003bb48174695
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 MYH11 COL12A1 ABCC9 SORBS1 PIEZO2 ATRNL1	7.02e-06	192	163	7	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FN1 PKHD1L1 DOCK5 PIEZO2 ALDH1A1 HOMER3 IGSF3	7.02e-06	192	163	7	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	Control-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	SH2D3C SRGAP2 DOCK5 SRGAP2C PTPRJ SRGAP2B SLAMF7	7.26e-06	193	163	7	3479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCell	facs-Pancreas-Exocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CP CAT CPB1 ADGRG6 ADAMTS9 ALDH1A1 SCARA3	7.26e-06	193	163	7	c3161a14a40323a58aa202c8a1d6ea0e9c2b9814
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID2 MYH9 COL12A1 FN1 ABCC9 PIEZO2 KIF14	7.51e-06	194	163	7	78dcb9d48259afabe73b41c5508a73a8d62339a4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 COL12A1 FN1 RAPGEF5 ABCC9 SORBS1 ATRNL1	7.76e-06	195	163	7	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	S1PR2 CPB1 PEX5L PKHD1L1 ATRNL1 CBLN2 C1QTNF1	7.76e-06	195	163	7	a52685f76eca269a7d2de8dfc317439483e233fa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 COL12A1 FN1 RAPGEF5 ABCC9 SORBS1 ATRNL1	7.76e-06	195	163	7	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID2 MYH9 MYH11 COL12A1 FN1 ABCC9 PIEZO2	7.76e-06	195	163	7	d760d1423f9a8a373fe7b250ea9b1d67a0c0059f
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	S1PR2 CPB1 PEX5L PKHD1L1 ATRNL1 CBLN2 C1QTNF1	7.76e-06	195	163	7	224deeba2f60def6543a55bb4f5ee6c7fdab3f02
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Club\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	GKN2 CP MFSD6L ADGRV1 FREM2 SULT2B1 ALDH1A1	8.03e-06	196	163	7	4e4c632db73b1340d80bf40a7657cb4821084d3c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 COL12A1 FN1 RAPGEF5 ABCC9 SORBS1 C1QTNF1	8.03e-06	196	163	7	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	distal-1-Endothelial-Lymphatic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYO7A PKHD1L1 PIEZO2 ADAMTS9 ATRNL1 SCARA3 HOMER3	8.57e-06	198	163	7	b6fea363463c8dd7e6780c085ece4900266a6286
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 COL12A1 FN1 RAPGEF5 ABCC9 SORBS1 ATRNL1	8.57e-06	198	163	7	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	PITPNM2 PDE1C MYH9 RAPGEF5 SH2D3C SORBS1 ADAMTS9	8.86e-06	199	163	7	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH11 FN1 ADGRG6 ATRNL1 PLXNA4 C1QTNF2 SCARA3	8.86e-06	199	163	7	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 FN1 SORBS1 TECTA ADAMTS9 C1QTNF1 SEL1L2	8.86e-06	199	163	7	8ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CNTN4 NID2 FN1 CP PLXNA4 SORCS3 SCARA3	8.86e-06	199	163	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	PITPNM2 CNTN4 NID2 PDE1C COL12A1 CPB1 PIEZO2	8.86e-06	199	163	7	60a653100aff31f7f96796ff2ec634798bfb4b0d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CNTN4 NID2 PLXNA4 SORCS3 C1QTNF1 ALDH1A1 SCARA3	8.86e-06	199	163	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Biopsy_IPF-Mesenchymal-Mesothelial_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	CPB1 PEX5L PKHD1L1 ADAMTS9 ATRNL1 C1QTNF1 SERTM1	9.15e-06	200	163	7	553386523fd8f8f36617a0d81032224b7ddce442
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH11 ADGRG6 DOCK5 ATRNL1 PLXNA4 C1QTNF2 SCARA3	9.15e-06	200	163	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH11 ABCC9 ADGRG6 ATRNL1 C1QTNF1 C1QTNF2 SCARA3	9.15e-06	200	163	7	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH11 ABCC9 ADGRG6 ATRNL1 C1QTNF1 C1QTNF2 SCARA3	9.15e-06	200	163	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH11 ABCC9 ADGRG6 ATRNL1 C1QTNF1 C1QTNF2 SCARA3	9.15e-06	200	163	7	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CABLES2 SH2D3C PARS2 TYR IFT122 ALG12	1.05e-05	135	163	6	c7c30b993b3ddac8f1677d5fe47dc2e66d0d26ac
ToppCell	Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Striatum / BrainAtlas - Mouse McCarroll V32	PCDHA7 CPB1 PCDHA3 SLC18A1 UPK3A	1.44e-05	84	163	5	9417fffe0ba79f5851920258dcd0f6c09218be13
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ENC1 PEX5L KCNJ4 CFAP61 ALOX12B SERTM1	1.46e-05	143	163	6	5fb5a4ea93e5cce55d427e3b4a50a979504fad3c
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PCDHA11 PCDHA7 PCDHA2 PCDHA1 SLAMF7	1.52e-05	85	163	5	642755ed2b562dd5e599a04a2b9730e8d29aefe8
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PCDHA11 PCDHA7 PCDHA2 PCDHA1 SLAMF7	1.52e-05	85	163	5	2429bacccd103e5b2414264b4aff3103ed9d7cec
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE1C CP TECTA CSMD3 CBLN2 IGSF3	2.31e-05	155	163	6	cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCell	AT1-AT2_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	EYA4 COL12A1 ABCC9 C1QTNF1 IGSF3 SERTM1	2.31e-05	155	163	6	010e45ef4b505bf419ea41e4d1619521d1c78319
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN4 MYH11 ABCC9 ADGRG6 ATRNL1 C1QTNF1	2.39e-05	156	163	6	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	PEX5L PKHD1L1 ATRNL1 CBLN2 SCARA3 SERTM1	2.39e-05	156	163	6	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN4 MYH11 ABCC9 ADGRG6 ATRNL1 C1QTNF1	2.48e-05	157	163	6	bfec34182f052cf1c0d847ba53ea335d4d1190de
Drug	blebbistatin	MYH9 MYH11 FN1 MYO7A SLC25A16 ACTR6 NRK DYNLL2 B4GALNT2	1.49e-07	116	162	9	CID003476986
Drug	cinnabarinic acid	CP CAT TYR	3.50e-06	5	162	3	CID000114918
Drug	dimethoxyphenol	CP TYR TOP2B	6.96e-06	6	162	3	CID000078828
Drug	anthocyanin	CAT GSR TYR YIPF1 SLC18A1 KCNJ4	1.06e-05	70	162	6	CID000145857
Drug	6-hydroxydopamine quinone	CP CAT TYR	1.21e-05	7	162	3	CID000204080
Drug	aminoacetone	CP CAT GSR	1.21e-05	7	162	3	ctd:C006495
Drug	argemone oil	CAT GSR TYR	1.21e-05	7	162	3	ctd:C030610
Drug	arjunolic acid	CP CAT GSR	1.93e-05	8	162	3	CID000073641
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.34e-22	29	160	13	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.55e-15	87	160	13	EFO_0004340, EFO_0004765
Disease	neutrophil count, basophil count	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 S1PR2 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PTPRJ	1.70e-12	224	160	15	EFO_0004833, EFO_0005090
Disease	Abnormality of refraction	PCDHA9 PKD1L1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ADAMTS9 ADAMTS20 PLA2G6 DYNLL1 SGF29	5.05e-09	673	160	19	HP_0000539
Disease	post-traumatic stress disorder symptom measurement	PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.59e-08	82	160	8	EFO_0008535
Disease	neuroticism measurement, cognitive function measurement	PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FPGT TYR SORCS3	8.69e-08	566	160	16	EFO_0007660, EFO_0008354
Disease	vital capacity	STRN3 EYA4 PCDHA9 TENT4B FN1 FRMPD1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 APOB PCDHA1 ZBTB24 ADGRG6 ABHD12	9.83e-07	1236	160	22	EFO_0004312
Disease	Nonsyndromic genetic hearing loss	MYH9 EYA4 MYO7A TRIOBP S1PR2 TECTA	3.70e-06	76	160	6	cv:C5680182
Disease	post-traumatic stress disorder	PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.54e-05	202	160	8	EFO_0001358
Disease	hearing impairment	EYA4 MYO7A TRIOBP ADGRV1 TECTA ABHD12	1.61e-05	98	160	6	C1384666
Disease	Autosomal dominant nonsyndromic hearing loss	MYH9 EYA4 MYO7A TECTA	1.78e-05	29	160	4	cv:C5779548
Disease	pulse pressure measurement	MYH11 PCDHA9 FN1 TRIOBP PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 ABCC9 PCDHA7 PCDHA6 S1PR2 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PIEZO2 SORCS3 DYNLL1	2.20e-05	1392	160	21	EFO_0005763
Disease	sensorineural hearing loss (is_implicated_in)	MYH9 EYA4 MYO7A TECTA	3.01e-05	33	160	4	DOID:10003 (is_implicated_in)
Disease	Protein Deficiency	CAT GSR	8.73e-05	3	160	2	C0033626
Disease	cortical thickness	PITPNM2 STRN3 EYA4 COL12A1 TRIOBP ABCC9 SRGAP2 ADGRV1 FMNL2 ADAMTS9 SRGAP3 ADAMTS20 DYNLL1 C1QTNF1 HAS3 SGF29 ABHD12	1.21e-04	1113	160	17	EFO_0004840
Disease	cholesteryl ester 20:3 measurement	CNTN4 MYH11 APOB TOMM40	1.46e-04	49	160	4	EFO_0010347
Disease	Hereditary hearing loss and deafness	MYH9 EYA4 MYO7A TRIOBP S1PR2 TECTA	1.50e-04	146	160	6	cv:C0236038
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A TRIOBP S1PR2 TECTA	1.71e-04	51	160	4	cv:CN043650
Disease	diabetic nephropathy	MYH9 RAPGEF5 SH2D3C SORBS1 PDILT SORCS3	1.74e-04	150	160	6	EFO_0000401
Disease	Cranioectodermal dysplasia	WDR19 IFT122	1.74e-04	4	160	2	cv:C4551571
Disease	Ureteral Calculi	CAT GSR	1.74e-04	4	160	2	C1456865
Disease	neutrophil count	EYA4 PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 S1PR2 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ADGRG6 PTPRJ SLC18A1 B4GALNT2	1.87e-04	1382	160	19	EFO_0004833
Disease	sex interaction measurement, bilirubin measurement	COL12A1 F2RL1 SORCS3	2.23e-04	22	160	3	EFO_0004570, EFO_0008343
Disease	Alzheimer disease, gastroesophageal reflux disease	EYA4 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CBLN2 B4GALNT2	2.57e-04	228	160	7	EFO_0003948, MONDO_0004975
Disease	CRANIOECTODERMAL DYSPLASIA 1	WDR19 IFT122	2.89e-04	5	160	2	C0432235
Disease	Hypoplastic Left Heart Syndrome	PCDHA9 PCDHA13	2.89e-04	5	160	2	C0152101
Disease	senile cataract (is_marker_for)	CAT GSR	2.89e-04	5	160	2	DOID:9669 (is_marker_for)
Disease	acute lymphoblastic leukemia	HTR1B OR5AL1 WDR19 PTPRJ	4.62e-04	66	160	4	EFO_0000220
Disease	hyperthyroidism (biomarker_via_orthology)	CP CAT GSR	4.64e-04	28	160	3	DOID:7998 (biomarker_via_orthology)
Disease	hearing loss	NID2 EYA4 TRIOBP TYR	4.89e-04	67	160	4	EFO_0004238
Disease	depressive symptom measurement	HTR1B PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TYR SORCS3	5.55e-04	426	160	9	EFO_0007006
Disease	Nephronophthisis, familial juvenile	WDR19 ADAMTS9	6.03e-04	7	160	2	C1855681
Disease	Diabetes Mellitus	FN1 CP CAT	6.91e-04	32	160	3	C0011849
Disease	Unilateral agenesis of kidney	FREM2 UPK3A	8.01e-04	8	160	2	C0266294
Disease	pulmonary function measurement	NID2 ADGRG6 CBLN2 UPK3A	8.28e-04	77	160	4	EFO_0003892
Disease	Nonsyndromic Deafness	EYA4 MYO7A ADGRV1 TECTA	1.00e-03	81	160	4	C3711374
Disease	cataract (is_marker_for)	CAT GSR	1.03e-03	9	160	2	DOID:83 (is_marker_for)
Disease	Colon Carcinoma	PTPRJ MUTYH	1.03e-03	9	160	2	C0699790
Disease	Hyperthyroidism	CAT GSR	1.03e-03	9	160	2	C0020550
Disease	Primary Hyperthyroidism	CAT GSR	1.03e-03	9	160	2	C3714618
Disease	late-onset Alzheimers disease	RAPGEF5 TECTA GPR180 ADAMTS20 CFAP74 DYNLL1 TOMM40	1.11e-03	292	160	7	EFO_1001870
Disease	diabetes mellitus (is_marker_for)	FN1 APOB GSR	1.43e-03	41	160	3	DOID:9351 (is_marker_for)
Disease	Congenital Nonbullous Ichthyosiform Erythroderma	SULT2B1 ALOX12B	1.56e-03	11	160	2	C0079154
Disease	beta thalassemia (is_marker_for)	APOB GSR	1.56e-03	11	160	2	DOID:12241 (is_marker_for)
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB B4GALNT2	1.56e-03	11	160	2	OBA_2045170
Disease	Colorectal Carcinoma	CNTN4 EYA4 FN1 APOB PEX5L CSMD3 SULT2B1 PDILT B4GALNT2 OLFM2 MUTYH	1.62e-03	702	160	11	C0009402
Disease	age-related hearing impairment	NID2 EYA4 TRIOBP CSMD3 TYR PLXNA4 DYNLL1	2.01e-03	324	160	7	EFO_0005782
Disease	Neurodegeneration with brain iron accumulation	CP PLA2G6	2.19e-03	13	160	2	cv:C2931845
Disease	Malignant neoplasm of breast	NID2 MYH9 FN1 ACADM STXBP4 FRMPD1 CAT SORBS1 GRIN2D TECTA GPR180 SRGAP3 ZFYVE26 DHX32	2.21e-03	1074	160	14	C0006142
Disease	melanoma	MYO7A CP F2RL1 TYR ADAMTS20 ALDH1A1	2.40e-03	248	160	6	C0025202
Disease	unipolar depression	RAPGEF5 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CSMD3 AQP7 ADGRG6 TYR PIEZO2 SORCS3 INTS9 CFAP61	2.42e-03	1206	160	15	EFO_0003761
Disease	1-methylurate measurement	CNTN4 SLC18A1	2.55e-03	14	160	2	EFO_0021173
Disease	free cholesterol to total lipids in small HDL percentage	TENT4A APOB TOMM40	2.69e-03	51	160	3	EFO_0022285
Disease	Yu-Zhi constitution type	FREM2 PIEZO2	2.93e-03	15	160	2	EFO_0007638
Disease	cervical carcinoma	GSAP ADGRV1 CBLN2 SLAMF7 EXOC7	3.21e-03	182	160	5	EFO_0001061
Disease	Huntington's disease (biomarker_via_orthology)	CAT GSR	3.34e-03	16	160	2	DOID:12858 (biomarker_via_orthology)
Disease	cholesterol to total lipids in large LDL percentage	TENT4A APOB TOMM40	3.51e-03	56	160	3	EFO_0022235
Disease	cholesterol to total lipids in IDL percentage	TENT4A APOB SLC18A1	4.27e-03	60	160	3	EFO_0022233
Disease	cutaneous melanoma	RAPGEF5 ADGRV1 TYR PLA2G6	4.33e-03	121	160	4	EFO_0000389
Disease	cutaneous melanoma, hair color	ADGRV1 TYR UPK3A	4.68e-03	62	160	3	EFO_0000389, EFO_0003924
Disease	level of Sterol ester (27:1/20:3) in blood serum	MYH11 NOMO1	4.70e-03	19	160	2	OBA_2045199
Disease	melanoma	COL12A1 ADGRV1 TYR PLA2G6	4.99e-03	126	160	4	EFO_0000756
Disease	Sarcomatoid Renal Cell Carcinoma	FPGT CSMD3 ALDH1A1 ALOX12B	5.28e-03	128	160	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	FPGT CSMD3 ALDH1A1 ALOX12B	5.28e-03	128	160	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	FPGT CSMD3 ALDH1A1 ALOX12B	5.28e-03	128	160	4	C1266044
Disease	Papillary Renal Cell Carcinoma	FPGT CSMD3 ALDH1A1 ALOX12B	5.28e-03	128	160	4	C1306837
Disease	Renal Cell Carcinoma	FPGT CSMD3 ALDH1A1 ALOX12B	5.28e-03	128	160	4	C0007134

Protein segments in the cluster

Peptide	Gene	Start	Entry
VAIYKASGIIHSYTL	AGBL5	501	Q8NDL9
YNAKIGYSHENVSVI	ACTR6	11	Q9GZN1
VNTDHILYTVYSTVG	HTR1B	201	P28222
KSSYIVSQIAVAYHN	CDC23	261	Q9UJX2
KLSDISTGYAQYHHV	CFAP61	346	Q8NHU2
TALHYAVYNKGTSLA	ANKRD18A	136	Q8IVF6
TSDFAVSAHGFKVYY	CSMD3	156	Q7Z407
VSAHGFKVYYEELQS	CSMD3	161	Q7Z407
AFGYFEVTHDITKYS	CAT	81	P04040
KFILQHVTYTSTGYQ	B4GALNT2	266	Q8NHY0
YTVYVVNISFHLSAG	ADGRG6	446	Q86SQ4
AIHKYGIENVKTYST	GSR	431	P00390
IYYGVKIQTNESHVT	ADGRV1	1381	Q8WXG9
AHFLDYYLLASVSQK	CCNJL	196	Q8IV13
VLYHLAVKAYNSAGT	CNTN4	871	Q8IWV2
YNHAKFLGVTELSAY	BTBD11	1031	A6QL63
YGFHEYTEVKTVTVK	ALDH1A1	481	P00352
GFVATTTSIVYYHNI	ABCC9	111	O60706
TYYASIAKAFAGDIA	ACADM	351	P11310
HYAVYNEDISVATKL	ANKRD26	151	Q9UPS8
KAITAGYFYHTARLT	DHX16	941	O60231
EGDHFTLISIYKAYQ	DHX32	541	Q7L7V1
KTITGVFNSSHYGYN	ADAMTS20	721	P59510
VFNSSHYGYNVVVKI	ADAMTS20	726	P59510
HLVVNAAYSATALYV	ALG12	351	Q9BV10
TALHYAVYNKGTSLA	ANKRD19P	136	Q9H560
HSYTGIIHAFKTIYA	SLC25A16	166	P16260
TIDHVKGDSFAYIQY	RBM15B	446	Q8NDT2
YVTNSHLAGAKVYFA	OLFM2	381	O95897
TTGTYTIHAQKEHLY	NOMO3	371	P69849
SYVSVHAESGKVYAL	PCDHA9	506	Q9Y5H5
IIQSHYEKVSYVSGS	INTS9	226	Q9NV88
AAKEVLYHLDIYFSS	INTS15	16	Q96N11
SYVSVHAESGKVYAL	PCDHA2	506	Q9Y5H9
SYISVHAESGKVYAL	PCDHA6	506	Q9UN73
HHPNIVSYYTSFVVK	OXSR1	71	O95747
VDYSRFHKTYEVAGT	KCNJ4	331	P48050
VLIFITEKHGNYFAY	NOL11	166	Q9H8H0
KVLSSLGYHVVTFDY	ABHD12	191	Q8N2K0
HSFQYKHRGVYSSDV	CP	1001	P00450
SYVSVHAESGKVYAL	PCDHA7	506	Q9UN72
KQAFDYAYVVLSHAV	TENT4B	381	Q8NDF8
YVSVHAESGKVYALQ	PCDHA11	506	Q9Y5I1
TYYVFGRHDISDKSS	KIF14	1106	Q15058
TTGTYTIHAQKEHLY	NOMO2	371	Q5JPE7
NYTYKIHVAGETDSS	PTPRJ	396	Q12913
SYISVHTESGKVYAL	PCDHA8	506	Q9Y5H6
SYVSVHAESGKVYAL	PCDHA3	506	Q9Y5H8
SFYQLIFSTVHGLYK	IFT122	346	Q9HBG6
TEHVYRVYVTTFLGF	ENTPD7	301	Q9NQZ7
AAATIYSLFYTAILH	AQP7P3	126	A6NL99
VVHSLYNKGFIYLDV	FAM91A1	211	Q658Y4
SNLLDYTEVKTHYGF	FREM2	2581	Q5SZK8
YTEVKTHYGFLTDAT	FREM2	2586	Q5SZK8
YFTYDITLANKHLAI	C1QTNF2	196	Q9BXJ5
GKHALTVSYFYDATR	HOMER3	31	Q9NSC5
NFGSYVTHETKHFIY	DYNLL1	61	P63167
VTHETKHFIYFYLGQ	DYNLL1	66	P63167
VVHFYGYSVVSTLAL	MFSD6L	321	Q8IWD5
IAYVYKNHSLAFVGT	PLXNA4	436	Q9HCM2
YRAPSHDKVASIFYT	OR2V1	266	Q8NHB1
YRAPSHDKVASIFYT	OR2V2	266	Q96R30
VTQTVHYLLYKTGVA	PDE1C	236	Q14123
VTISASEKGYYFHTE	PEX5L	306	Q8IYB4
IVFLVVYKAFTYDHS	NSG2	86	Q9Y328
SYHTLAYVHTTGQVV	HERC6	296	Q8IVU3
TTGTYTIHAQKEHLY	NOMO1	371	Q15155
QYYSHFTALGLQKID	KIF24	16	Q5T7B8
KVIQYLAYVASSHKS	MYH9	186	P35579
AAATIYSLFYTAILH	AQP7	126	O14520
LANYIHFSSYSKDGI	GPR180	221	Q86V85
YVSVHAESGKVYALQ	PCDHA5	506	Q9Y5H7
AAYGSTKDVAVYSAI	PITPNM2	1206	Q9BZ72
HVISYYHVASDTEKI	EXOC7	86	Q9UPT5
KQVFDYAYIVLSHAV	TENT4A	481	Q5XG87
NYVSVHAESGKVYAL	PCDHA1	506	Q9Y5I3
SYVSVHAESGKVYAL	PCDHA13	506	Q9Y5I0
YVSVHAESGKVYALQ	PCDHA10	506	Q9Y5I2
TEYGLSVYKDHQTIT	MCM3	186	P25205
SANFTAHISPYKELY	NID2	656	Q14112
SYVSVHAESGKVYAL	PCDHA4	506	Q9UN74
YFLIKSQGQSHVYAL	F2RL1	311	P55085
FAVDETSVSGYIYHK	UPF1	441	Q92900
QITYSVFYIHKGHSK	GSAP	306	A4D1B5
VYSKVHNGSEILFSY	APOB	4231	P04114
FYKGYVNTNSEHTAV	ADAMTS9	151	Q9P2N4
IVFHSLLTGSYAQKY	EYA4	381	O95677
LKTTHNSAFEYGTYA	IGSF3	731	O75054
TTIFDYKHGYIASRV	GKN2	61	Q86XP6
TYITFSGYLVKHATE	C1QTNF1	266	Q9BXJ1
FSTIHTYGLYVNFKN	DOCK5	216	Q9H7D0
LTRTEVYKTGVTHYF	SDR42E1	311	Q8WUS8
GENVFSYHITYKEAA	COL12A1	656	Q99715
SYVGLVTVRAYSHSV	FCGBP	526	Q9Y6R7
VTYYFKVFAVSHGRE	FN1	971	P02751
DVVYTYHQFIEAAKS	FRMPD1	1526	Q5SYB0
NVAYTTGKLSFHTDY	BBOX1	191	O75936
GIYSFSFHVVKVYNR	CBLN2	141	Q8IUK8
TSVYDEITKSIYVHG	ATRNL1	471	Q5VV63
FYNELHYVEKAAAVS	FMNL2	881	Q96PY5
YVTIVIYTCSAKHAA	ALOX12B	566	O75342
LAAYVTGYQFIHTEK	HAS3	26	O00219
TGYQFIHTEKHYLSF	HAS3	31	O00219
GSINIYLFHKSSYAD	ENC1	16	O14682
KYLAVASHDSFIDIY	EML5	1096	Q05BV3
VGFYSAYSVAEKVTV	HSP90AA4P	76	Q58FG1
SGYTLDQTYAKIHFT	MT-CO1	401	P00395
ILYKAHYFFAVSTLN	S1PR2	266	O95136
THAEELYYLNKSVSI	SCARA3	391	Q6AZY7
EFSYQIGNTSKHTLY	PKD1L1	1226	Q8TDX9
TFLAIKYVASYVLEH	CPB1	401	P15086
SYAKFLYPTNALVTH	CABLES2	241	Q9BTV7
LSHYQIKFAATALYD	CFAP74	1021	Q9C0B2
KNDTTGIHSVYTVYQ	GARNL3	256	Q5VVW2
NSKFYHIGTTEEYLF	FPGT	366	O14772
NFGSYVTHETKHFIY	DYNLL2	61	Q96FJ2
VTHETKHFIYFYLGQ	DYNLL2	66	Q96FJ2
LDVAYAYGKLSFHQT	TBRG4	296	Q969Z0
HLTVVSIFYGAAFYT	OR2T11	241	Q8NH01
LHYSVYEEAKHGTFV	PCDHA12	31	Q9UN75
SYVSVHAESGKVYAL	PCDHA12	506	Q9UN75
YTVKFYDGVVQTVKH	PHF20	116	Q9BVI0
HLTAVALFYGSIIYV	OR1L6	281	Q8NGR2
TYIAIALKSSIHLYA	NRK	1326	Q7Z2Y5
SESYGIIIQHYKLAS	PDILT	286	Q8N807
VGTVHNFYYSAQKVE	TAS2R41	61	P59536
EVGHTFYLGTKYSSI	PARS2	306	Q7L3T8
SIYDVAFHSSKAYIA	STRN3	771	Q13033
DVVVSLYHYSKIAGQ	SULT2B1	151	O00204
LYGTATKHLTYNDFI	TOP2B	706	Q02880
YVGDAYLVLHTAKTS	SCIN	41	Q9Y6U3
HVYKSAGIFQVTAYA	SORCS3	881	Q9UPU3
GTKKDYQTAATHYSI	SEL1L2	566	Q5TEA6
NFYTYSVAKGNHSTV	OR5AL1	11	P0C617
HVYITEHSYVSVKAK	RAPGEF5	246	Q92565
ALEATNASVFKYYIH	SRGAP2C	256	P0DJJ0
ALEATNASVFKYYIH	SRGAP2B	256	P0DMP2
HTFSHIKLTYQVYGL	MUTYH	441	Q9UIF7
SYPHYVKSIVASTFI	MT-ND5	31	P03915
VYTYVFHKDTIQGAK	WDR19	581	Q8NEZ3
VTDYKGETVFHYAVQ	PLA2G6	181	O60733
GHLSNVYIYVSIFLS	SERTM1	36	A2A2V5
YTADGIKYFINHVTQ	STXBP4	506	Q6ZWJ1
FTSGKYQDVYVELSH	TRIOBP	2316	Q9H2D6
KYQTIHSTGFLASRY	C15orf39	216	Q6ZRI6
SIIHYAGKVDYNASA	MYH11	576	P35749
FGYSIVIHRAYKHTV	TECTA	1166	O75443
KAFTHYSTYVLHERA	ZNF460	371	Q14592
SNFLIHLGEKTYHYV	YIPF1	141	Q9Y548
ASVYKLYFGIFIVAH	XKR7	321	Q5GH72
ENYSNLVSVGYHVSK	ZNF334	41	Q9HCZ1
NLAATNAAISKYYIH	SRGAP3	246	O43295
TDSYYKGQTALHIAI	TRPV1	196	Q8NER1
TVVLYFSHLKEYVAS	TRPV1	526	Q8NER1
IGLVIYYLAFSAKSH	SSR4	156	P51571
ILAEVVSYSHATNKY	SGF29	176	Q96ES7
ALEATNASVFKYYIH	SRGAP2	256	O75044
GYIYSSNFHAVKRES	SORBS1	651	Q9BX66
SYYFLHVVADIKASQ	PIEZO2	1431	Q9H5I5
AYLTLAKHTISSDYV	TYR	136	P14679
VYAVAISGSTHHVYT	TLE7	161	A0A1W2PR48
SKEALTGTHEVYLYV	UPK3A	51	O75631
TGTHEVYLYVLVDSA	UPK3A	56	O75631
SQSFYVDVVYIGHTS	PKHD1L1	821	Q86WI1
STQEYVLHVYEHLSK	SLAMF7	116	Q9NQ25
ESNYHFGVTYVGTKQ	TOMM40	126	O96008
LEFIYTGYLHASEKS	ZBTB24	91	O43167
ASGEIKIAYTYSVSF	TM9SF2	261	Q99805
YAVHYFFSKLQITGT	TM9SF2	606	Q99805
AYNSYLAKHSIIHTG	ZNF28	421	P17035
HVYQHTAAVVSAKSY	ZNF821	136	O75541
VVKAGESYTHIQYLF	SH2D3C	271	Q8N5H7
FAYNSYLAKHTILHT	ZNF468	336	Q5VIY5
ANYLTTHFYGQLTAV	ZFYVE26	1631	Q68DK2
RHTSVYGSVYAIADV	SLC18A1	421	P54219
DHLIYTYTGSILVAV	MYO7A	91	Q13402
QHKIYTYTGSILVAV	MYO7B	91	Q6PIF6
AHTIGFSYDLYLVTN	GRIN2D	496	O15399